期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非典型抗精神病药物临床应用现状分析 被引量：4

在线阅读 下载PDF
导出
摘要 目的探讨临床医师对利培酮、再普乐、思瑞康三种非典型抗精神病药物临床应用现状。方法对我院精神科门诊连续五个工作日处方中应用利培酮、再普乐、思瑞康三种药物之一的142张处方进行分析。结果利培酮应用频度最高,多用于治疗精神分裂症的复诊患者;再普乐应用频度较少,多用于男性、年长、初诊精神分裂症;思瑞康多用于女性初诊精神分裂症。结论三种非典型抗精神病药物均被临床普遍应用,但由于药物的各自特点,所选择的适应对象和适应症有所不同。
作者 李植荣 高镇松
机构地区 汕头市第四人民医院
出处 《临床心身疾病杂志》 CAS 2006年第4期306-307,共2页 Journal of Clinical Psychosomatic Diseases
关键词 非典型抗精神病药 利培酮 再普乐 思瑞康
分类号 R749.053 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献3

二级参考文献10

  • 1Fleischhacker WW. New developments in the pharmacotherapy of schizophrenia. J Neural Transm Suppl 2003;64:105-117.
  • 2Potkin SG, Saha AR, Kujawa MJ, et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 2003;60:681-690.
  • 3Baker RW, Kinon B J, Maguire GA, et al. Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol2003;23:342-348.
  • 4Casey DE, Daniel DG, Wassef AA, et al. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 2003;28:182-192.
  • 5Kane JM, Carson WH, Saha AR, et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 2002;63:763-771.
  • 6Lieberman J, Carson WH, Saha AR, et al. Meta-analysis of the efficacyof aripiprazole in schizophrenia. Int J Neuropsychopharmacol 2002;5(suppl 1):S186mania associated with bipolar disorder (STAMP 1 and STAMP 2). In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 20, 2003; San Francisco, Calif.Abstract NR432:162.
  • 7Carson WH, Pigott TA, Saha AR, et al. Aripiprazole vs. placebo in the treatment of chronic schizophrenia [poster]. Presented at the 42nd annual meeting of the New Clinical Drug Evaluation Unit; June 10-13, 2002; Boca Raton, Fla.
  • 8Marder SR, Essock SM, Miller AL, et al. The Mount Sinai conference on the pharmacotherapy of schizophrenia. Schizophr Bull 2002;28:5-16.
  • 9Leucht S, Barnes TRE, Kissling W, et al. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized-controlled trials. Am J Psychiatry 2003;160:1209-1222.
  • 10Fleischhacker WW, Eerdekens M, Karcher K, et al. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month evaluation of the first long-acting second-generation antipsychotic. J Clin Psychiatry 2003 ;64:1250-1257.

共引文献3

同被引文献45

  • 1孔庆建,张辉,孙波,张德军.肠易激综合征的病因与发病机制[J].中国煤炭工业医学杂志,2006,9(10):1033-1034. 被引量：13
  • 2张明园.精神科评定量表手册.精神卫生评定量表[M].湖南科学技术出版社,1989.120-150.
  • 3刘碧秀,张程赪,张宝强,王齐立.护理干预对首发精神分裂症患者疗效的影响[J].临床心身疾病杂志,2007,13(4):333-334. 被引量：2
  • 4Thompson WG,Longstreth G,Drossman DA,et al.Functional bowel disorder's and functional abdominal pain[M].In:Drossman DA,Corazziali E,Talley NJ,eds,Rome Ⅱ.The functional gastrointestinal disorders.Diagnosis,pathophysiology and treatment:a multinational consensus.2nd ed.USA.Mclean.Va:Degnon Assocates,2000.351-432.
  • 5Creed F.Health related quality of life and healthcare costs in severe refractory IBS[M].Annals of Internal Medicine,2001,134:860.
  • 6方吉乾,陆盈.现代医学统计学[M].北京:人民卫生出版社.2002.150-209.
  • 7Yang LP, Plosker GL. Paliperidone extended release [J].CNS Drugs, 2007, 21(5): 417.
  • 8Spina E, Cavallaro R. The pharmacology and safety of paliperidone extended-release in the treatment of schizophre- nia [J]. Expert Opin Drug Saf, 2007, 6(6): 651.
  • 9Dolder C. Review: paliperidone reduces symptoms of schizophrenia and schizophrenia-like illness [J]. Evid Based Ment Health, 2008, 11(4): 114.
  • 10Janicak PG,Winans EA. Paliperidone ER:a review of the clinical trial data[J].Neuromuscular Disorders,2007,(06):869.

引证文献4

二级引证文献14

临床心身疾病杂志
2006年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
关于我们 | 版权声明 | 联系我们 | 帮助中心| 意见反馈
主办单位：上海市教育委员会
技术支持：重庆维普资讯有限公司
渝公网安备 50019002500403号
使用帮助 返回顶部